Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

  1. Macias, V.A.
  2. Barrera-Mellado, I.
Revue:
BJU International

ISSN: 1464-410X,  1464-4096

Année de publication: 2020

Volumen: 125

Número: 2

Pages: 215-225

Type: Article

DOI: 10.1111/BJU.14925 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus